Status:
UNKNOWN
Multi-parametric Ultrasound Versus Multi-parametric MRI for Prostate Cancer Detection
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Conditions:
PROSTATE CANCER
Prostate Biopsy
Eligibility:
MALE
Phase:
NA
Brief Summary
The goal of this cohort study is to investigate multiparametric ultrasound versus multiparametric MRI for clinically significant prostate cancer detection in patients scheduled for initial biopsy. The...
Detailed Description
In recent years, the multi-parametric MRI targeted biopsy showed inspiring results for improving clinically significant prostate cancer (PCa) detection rate \[1\]. Two techniques have been developed f...
Eligibility Criteria
Inclusion
- Scheduled for prostate biopsy;
- Signed the informed consent.
Exclusion
- Contraindications to MRI, such as metal implants, claustrophobia, etc;
- Contraindications to ultrasound, such as acute myocardial infarction, acute cerebral infarction and rectal tumor after Miles operation;
- Contraindications of prostate biopsy, such as abnormal routine urine test, coagulation function and electrocardiogram
- Any medical condition or other event that may significantly reduce the chances of obtaining reliable data, achieving the purpose of the study or completing the study and follow-up;
- The study doctor thinks it is not suitable to participate in this study.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06183905
Start Date
December 1 2023
End Date
December 31 2025
Last Update
December 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China, 200092